In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
395 News Items found
Section of a lung cancer tumor in mice
Finding
A Never-Before-Seen Cell State May Explain Cancer’s Ability to Resist Drugs

Identified in mice, this unusual cell state emerges early during tumor evolution and gives tumors enormous malleability.
Pictured: Timothy Chan
In the Lab
Investigators Sequence the Genome of a Rare Head and Neck Cancer

Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan Kettering.
Memorial Sloan Kettering medical oncologist Eileen O'Reilly
Vaccine Targeting KRAS in Pancreatic and Colorectal Cancer Shows Promise

Read about a therapeutic vaccine that could potentially prevent certain pancreatic and colorectal cancers from returning.
Dr. Alison Schram
FDA Approves Zenocutuzumab for Cholangiocarcinoma Based on MSK-Led Trial

The FDA has approved zenocutuzumab (Bizengri®) for adults with advanced, unresectable, or metastatic cholangiocarcinoma driven by a molecular change called an NRG1 gene fusion, based on a trial led by an MSK investigator.
Detail shot of an MSK scientist in the lab
MSK Research Highlights, January 29, 2024

New MSK research provides insights into how BRCA2 promotes genomic integrity; illuminates how embryonic cells can develop without key amino acids; explores how the microbiome bounces back after antibiotic treatment; and investigates acquired resistance to immunotherapy in non-small cell lung cancer.
Pictured: Craig Thompson
Perspective
President Craig Thompson Reflects on 40-Year War on Cancer

Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain.
Blood vessels supply tumors with the nutrients they need to grow.
Decoder
What Is Angiogenesis?

Cancer biologist Robert Benezra explains angiogenesis, the process by which new blood vessels form, and how it relates to cancer research.
The latest results come from a team of MSK physicians and scientists (from left to right): Bob Li, Hai-Yan Tu, Mackenzie Myers, Flavia Michelini, Emiliano Cocco, Sandra Misale, and Maurizio Scaltriti
In the Clinic
Back-to-Back Studies Support the Use of HER2-Targeted Therapies in Multiple Cancers

Results from a clinical trial and animal studies provide support for targeting the HER2 protein in multiple cancer types.
Breast cancer patient LaDawn Jefferson poses outside with her running medals
Living With Stage 4 Cancer

For those living with advanced cancer, quality of life means pursuing what matters most to each person — whether that’s making art, running marathons, caring for others, or spending more time with family.
Cartoon of a hand offering cigarettes and another hand declining them.
Feature
6 Reasons to Quit Smoking if You Have Cancer

Learn from MSK experts about how to quit smoking if you have cancer. It starts with having honest conversations about smoking and nicotine addiction.